COVID-19 vaccine could already be ready by October in the U.S., as announced by President Donald Trump to reporters on Friday, September 5 during a briefing at the White House.

Trump announced that they remain on track in their goal of delivering a vaccine before the end of the year and just maybe even before November 1 as they think they can probably have it some time in the month of October.

This is not surprising as Trump has been fixating on getting a vaccine out for the SARS-CoV-2 that during U.S. Pandemic Response meetings, nothing else captures his attention.

Administration officials said that the President had urged health officials to fast track the vaccine timeline and deliver a vaccine before 2020 ends.

He has been asking many questions about the status of the COVID-19 vaccine development and plans for mass distribution, according to a report by The Washington Post.

Vaccinating all of the Americans would be a huge undertaking considering that the U.S. has a population of more than 300 million.

As of late, Trump has been telling his advisers and aides that a vaccine may arrive by November 1.

National Institute of Allergy and Infectious Diseases Director, Anthony S. Fauci, agreed that a vaccine could already be available before 2020 ends. 

Fauci, however, said that it is unlikely that the efficacy and safety of a vaccine will be determined by October, although, it can still be possible.

According to the director, the public may be able to utilize a COVID-19 vaccine plausibly by November or December or early 2021.

Trump's urging of a fast research, development, trials and distribution of a vaccine is demonstrative of his highest priority and that is the health and safety of the Americans.

The President has cut through the red tape that would hamper a fast launching of a trial because he knows how important it is for the vaccine not to be entangled in government bureaucracy.

According to the National Geographic, the Operation Warp Speed initiative of the U.S. government has pledged $10 billion for the development of 300 million doses of a COVID-19 vaccine which is safe and effective and ready to be delivered by January 2021.   

The U.S. initiative is one of the many efforts in being able to market a vaccine soon to help ease the global crisis.

There are more than 150 vaccines being developed worldwide with scientists having started back in January.

Normally, it takes years for a safe and effective vaccine to be developed.

However, the scientists are speeding up the process with the aim of producing a COVID-19 vaccine by 2021. 

The New York Times tracker has 91 vaccines in preclinical testing around the world.

To date, there is only one COVID-19 vaccine that is already in the third phase of testing, Russia's Gamaleya.

While China, where the virus originated, has already approved the Sinovac vaccine for limited use. 

Check these out: 

U.S. COVID-19 Deaths: 94 Percent of People Who Died had Contributing Conditions, CDC Reports

Coronavirus Vaccine Needs to be Administered in Two Doses, Potential Problems Seen

J&J Recruits 20,000 People in Latin America for the COVID-19 Vaccine Trials